Sun-03-10-2021, 10:58 AM
(Sun-03-10-2021, 03:27 AM)KatT Wrote: Hope it becomes available here soon
Quote:
Montreal, Quebec, April 18, 2019 – AbbVie (NYSE: ABBV), a global research and
development-based biopharmaceutical company, announced today that Health Canada has
approved SKYRIZI™ (risankizumab) for the treatment of moderate to severe plaque psoriasis in
adult patients who are candidates for systemic therapy or phototherapy.